MD Anderson, Accelerator bake up Magnolia, an NYC biotech in neuroprotection, with $31M series AAllbiopro2018-08-14T00:29:20+09:008월 14th, 2018|
Orchard Therapeutics Nabs $150 Million in Series C FundingAllbiopro2018-08-14T00:28:43+09:008월 14th, 2018|
Alnylam’s success brings first RNAi therapeutic to USAllbiopro2018-08-14T00:28:17+09:008월 14th, 2018|
Best of both worlds: Combining two skeleton-building chemical reactionsAllbiopro2018-08-14T00:27:22+09:008월 14th, 2018|
Key role found for enzymes in DNA replication and sensitivity to chemotherapeutic drugsAllbiopro2018-08-14T00:26:54+09:008월 14th, 2018|
Creating a family tree for each body cell in real timeAllbiopro2018-08-14T00:26:26+09:008월 14th, 2018|
States say Alvogen lawsuit is part of a ‘guerilla’ war against the death penaltyAllbiopro2018-08-11T10:25:59+09:008월 11th, 2018|
Pfizer’s Besponsa, Lilly’s Taltz rack up reimbursement wins at NICEAllbiopro2018-08-11T10:25:31+09:008월 11th, 2018|
FDA found big problems a year ago at Chinese plant now recalling tainted valsartanAllbiopro2018-08-11T10:25:03+09:008월 11th, 2018|
Astellas absorbs U.K. ocular gene therapy player QuetheraAllbiopro2018-08-11T10:24:35+09:008월 11th, 2018|
Artios bags $84M to trial next-generation DNA damage response drugsAllbiopro2018-08-11T10:24:08+09:008월 11th, 2018|
Vernalis, weakened by FDA rejections, accepts £33M Ligand bid Allbiopro2018-08-11T10:23:41+09:008월 11th, 2018|
Emergent: $270m PaxVax acquisition and Baltimore expansion boost CDMO bizAllbiopro2018-08-11T10:23:15+09:008월 11th, 2018|
Molecular switch may serve as new target point for cancer and diabetes therapiesAllbiopro2018-08-11T10:21:56+09:008월 11th, 2018|
How to protect yeast from damage in biofuel productionAllbiopro2018-08-11T10:21:27+09:008월 11th, 2018|
